Editas Medicine, Inc. (EDIT)
2.60
+0.16
(+6.56%)
USD |
NASDAQ |
Dec 10, 16:00
2.605
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Profit Margin (Quarterly): -333.0% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 27.14% |
| Arcutis Biotherapeutics, Inc. | 7.47% |
| Daré Bioscience, Inc. | -154.9K% |
| Cogent Biosciences, Inc. | -- |
| Janux Therapeutics, Inc. | -243.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -246.7% |
| Return on Assets | -74.28% |
| Return on Invested Capital | -150.0% |
| Gross Profit Margin (Quarterly) | 90.44% |
| Operating Margin (Quarterly) | -325.4% |
| Return on Net Operating Assets | -490.1% |